Showing results (711-720 of 757) with videos related to

Sort By:
Pageof 76
Annals of the Rheumatic Diseases|June 7, 2013
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritisM M Schoels, J Braun, M Dougados, et al.
Science (New York, N.Y.)|October 9, 2020
Widespread carbon-bearing materials on near-Earth asteroid (101955) BennuAmy A Simon, Hannah H Kaplan, Victoria E Hamilton, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Science (New York, N.Y.)|October 13, 2007
New horizons mapping of Europa and GanymedeW M Grundy, B J Buratti, A F Cheng, et al.
Autoimmunity Reviews|December 25, 2010
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseasesS van Assen, O Elkayam, N Agmon-Levin, et al.
Rheumatology (Oxford, England)|July 11, 2000
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritisP Emery, F C Breedveld, E M Lemmel, et al.
Annals of the Rheumatic Diseases|December 7, 2010
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesS van Assen, N Agmon-Levin, O Elkayam, et al.
Arthritis and Rheumatism|August 16, 2000
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine aloneS M Proudman, P G Conaghan, C Richardson, et al.
Annals of the Rheumatic Diseases|August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)J L Nam, E Villeneuve, E M A Hensor, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapseC H Burgoyne, S L Field, A K Brown, et al.
Pageof 76